Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPIPA5 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | MARK1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | DUSP26 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | SPNS3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | CAMK2B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | MS4A6A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | ZNF461 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |